Mitsubishi Tanabe Pharma Corporation is a research-based pharmaceutical company, created through the merger of Tanabe Seiyaku Co., and Mitsubishi Pharma Corporation dated 1st October 2007, based in Osaka, Japan.

The company is committed to becoming a global research-driven pharmaceutical company, which continuously brings to market drugs that meet global needs. As part of the company's worldwide expansion, organisations have been established in Europe (Mitsubishi Pharma Europe Ltd) and the USA (Mitsubishi Pharma America Inc). The European infrastructure is expanding with the establishment of an office in Germany (Mitsubishi Pharma Deutschland GmbH).

For more information, please click here to visit the Mitsubishi Tanabe Pharma Corporation website.